Log In
Print
BCIQ
Print
Print this Print this
 

TAS-2913

  Manage Alerts
Collapse Summary General Information
Company Taiho Pharmaceutical Co. Ltd.
DescriptionOral mutant EGFR (T790M) selective inhibitor
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today